Operating Income (Loss) in USD of Biostax Corp. from Q2 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Biostax Corp. quarterly/annual Operating Income (Loss) history and change rate from Q2 2012 to Q2 2024.
  • Biostax Corp. Operating Income (Loss) for the quarter ending 30 Jun 2024 was -$300K, a 31.4% increase year-over-year.
  • Biostax Corp. Operating Income (Loss) for the twelve months ending 30 Jun 2024 was -$1.21M, a 20.8% increase year-over-year.
  • Biostax Corp. annual Operating Income (Loss) for 2023 was -$1.48M, a 27.6% decline from 2022.
  • Biostax Corp. annual Operating Income (Loss) for 2022 was -$1.16M, a 57.6% decline from 2021.
  • Biostax Corp. annual Operating Income (Loss) for 2021 was -$738K, a 16.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Biostax Corp. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1.21M -$300K +$137K +31.4% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 -$1.35M -$265K +$136K +34% 01 Jan 2024 31 Mar 2024 10-Q/A 19 Aug 2024
Q4 2023 -$1.48M -$293K -$24.4K -9.09% 01 Oct 2023 31 Dec 2023 10-K/A 05 Jul 2024
Q3 2023 -$1.46M -$352K +$68.5K +16.3% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 -$1.53M -$437K -$145K -49.8% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024
Q1 2023 -$1.38M -$402K -$220K -121% 01 Jan 2023 31 Mar 2023 10-Q/A 19 Aug 2024
Q4 2022 -$1.16M -$269K -$122K -83% 01 Oct 2022 31 Dec 2022 10-K/A 05 Jul 2024
Q3 2022 -$1.04M -$421K -$306K -267% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$735K -$292K -$103K -54.3% 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023
Q1 2022 -$632K -$182K +$106K +36.8% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$738K -$147K +$196K +57.1% 01 Oct 2021 31 Dec 2021 10-K 10 Apr 2023
Q3 2021 -$934K -$115K +$16.5K +12.6% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$950K -$189K -$171K -951% 01 Apr 2021 30 Jun 2021 10-Q 24 Aug 2022
Q1 2021 -$779K -$287K +$108K +27.3% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022
Q4 2020 -$887K -$343K +$1M +74.5% 01 Oct 2020 31 Dec 2020 10-K 18 Mar 2022
Q3 2020 -$1.89M -$131K +$258K +66.3% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$2.15M -$18K +$479K +96.4% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$2.63M -$395K +$212K +34.9% 01 Jan 2020 31 Mar 2020 10-Q 24 May 2021
Q4 2019 -$2.84M -$1.34M -$477K -55% 01 Oct 2019 31 Dec 2019 10-K 15 Apr 2021
Q3 2019 -$2.36M -$389K +$261K +40.2% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 -$2.62M -$497K +$1.08M +68.5% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$3.7M -$607K +$381K +38.6% 01 Jan 2019 31 Mar 2019 10-Q 30 Jun 2020
Q4 2018 -$4.08M -$868K +$713K +45.1% 01 Oct 2018 31 Dec 2018 10-K/A 28 Aug 2020
Q3 2018 -$4.8M -$650K +$799K +55.1% 01 Jul 2018 30 Sep 2018 10-Q 19 Nov 2019
Q2 2018 -$5.6M -$1.58M -$210K -15.4% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$5.39M -$988K +$528K +34.8% 01 Jan 2018 31 Mar 2018 10-Q 20 May 2019
Q4 2017 -$5.91M -$1.58M +$2.37M +60% 01 Oct 2017 31 Dec 2017 10-K 16 Apr 2019
Q3 2017 -$8.29M -$1.45M +$1.24M +46.2% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$9.53M -$1.37M +$1.28M +48.3% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 -$10.8M -$1.52M +$3.46M +69.6% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$14.3M -$3.95M +$3.96M +50% 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018
Q3 2016 -$18.2M -$2.69M -$140K -5.5% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$18.1M -$2.65M -$195K -7.96% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$17.9M -$4.98M -$2.09M -72.5% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017
Q4 2015 -$15.8M -$7.91M +$6.3M +44.3% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 -$22.1M -$2.55M +$4.53M +64% 01 Jul 2015 30 Sep 2015 10-Q 15 Nov 2016
Q2 2015 -$26.6M -$2.45M +$4.01M +62.1% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$30.6M -$2.89M +$14.6M +83.5% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 -$45.3M -$14.2M +$30.7M +68.3% 01 Oct 2014 31 Dec 2014 10-K/A 16 May 2016
Q3 2014 -$75.9M -$7.09M +$12.7M +64.1% 01 Jul 2014 30 Sep 2014 10-Q/A 22 Dec 2015
Q2 2014 -$88.6M -$6.47M +$13.5M +67.6% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$102M -$17.5M -$6.12M -53.8% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q4 2013 -$96M -$44.9M 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015
Q3 2013 -$19.7M -$19.4M -6111% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 -$20M -$19.7M -7092% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$11.4M 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q3 2012 -$318K 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 -$278K 01 Apr 2012 30 Jun 2012 10-Q 13 Aug 2013

Biostax Corp. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.48M -$321K -27.6% 01 Jan 2023 31 Dec 2023 10-K/A 05 Jul 2024
2022 -$1.16M -$425K -57.6% 01 Jan 2022 31 Dec 2022 10-K/A 05 Jul 2024
2021 -$738K +$149K +16.8% 01 Jan 2021 31 Dec 2021 10-K 10 Apr 2023
2020 -$887K +$1.95M +68.7% 01 Jan 2020 31 Dec 2020 10-K 18 Mar 2022
2019 -$2.84M +$1.25M +30.5% 01 Jan 2019 31 Dec 2019 10-K 15 Apr 2021
2018 -$4.08M +$1.83M +30.9% 01 Jan 2018 31 Dec 2018 10-K/A 28 Aug 2020
2017 -$5.91M +$8.36M +58.6% 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019
2016 -$14.3M +$1.53M +9.69% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018
2015 -$15.8M +$29.5M +65.1% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
2014 -$45.3M +$50.7M +52.8% 01 Jan 2014 31 Dec 2014 10-K/A 16 May 2016
2013 -$96M +$57.1M +37.3% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 -$153M 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.